Skip to main content
. 2017 Dec 16;23:5951–5959. doi: 10.12659/MSM.907592

Figure 1.

Figure 1

Validation of PHZ-induced neonatal hemolytic hyperbilirubinemia. Following PHZ administration, significant decreases in (A) serum hemoglobin and (B) serum hematocrit validated PHZ-induced hemolysis. Moreover, following PHZ administration, significant increases in (C) total serum bilirubin and (D) direct serum bilirubin validated PHZ-induced hyperbilirubinemia. All experiments were performed in triplicate. Data are reported as means ± standard errors of the mean (SEMs). * p<0.05 vs. control group.